Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Mitacs brings innovation to more people in more places across Canada and around the world.
Learn MoreWe work closely with businesses, researchers, and governments to create new pathways to innovation.
Learn MoreNo matter the size of your budget or scope of your research, Mitacs can help you turn ideas into impact.
Learn MoreThe Mitacs Entrepreneur Awards and the Mitacs Awards celebrate inspiring entrepreneurs and innovators who are galvanizing cutting-edge research across Canada.
Learn MoreDiscover the people, the ideas, the projects, and the partnerships that are making news, and creating meaningful impact across the Canadian innovation ecosystem.
Learn MoreThis project involves the research and development of a new skin examination system for Elucid Labs Inc. (Elucid) to add to its imaging and diagnostic capabilities in the area of skin cancer, disease, and conditions. Elucid is building a comprehensive system that identifies and tracks a patients’ moles to perform screening and risk assessment. Moreover, Elucid will be developing a multimodal microscopy system that may prove to be useful in streamlining the histopathology process pertaining to skin biopsies. The overall goal of this project is to provide a comprehensive system that can provide timely information to a specialist or a family physician in a consistent and easy manner without subjectivity.
David Clausi
Helmut Neher
Elucid Labs
Engineering
Medical devices
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.